drugset / Trial / NCT04499313
Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19
RandomizedParallel-groupOpen-labelTreatment
Summary
A randomized clinical trial designed and intended to evaluate the efficacy of Dexamethasone and Methylprednisolone as a treatment for severe Acute Respiratory Distress Syndrome (ARDS) caused by coronavirus disease 19 (COVID-19). Our aim is to find the best option for the treatment and management of ARDS in COVID-19 patients.
Timeline
- Start
- 2020-08-02
- Primary completion
- 2020-11-15
- Completion
- 2020-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexamethasone | Small molecule | 20 mg | Intravenous |
| Comparator | Methylprednisolone | Other / unclassified | 0.5 mg/kg | — |